Literature DB >> 23758150

Chronic chlorpyrifos exposure does not promote prostate cancer in prostate specific PTEN mutant mice.

Robert U Svensson1, Nadine L Bannick, Maximo J Marin, Larry W Robertson, Charles F Lynch, Michael D Henry.   

Abstract

Environmental factors are likely to interact with genetic determinants to influence prostate cancer progression. The Agricultural Health Study has identified an association between exposure to organophosphorous pesticides including chlorpyrifos, and increased prostate cancer risk in pesticide applicators with a first-degree family history of this disease. Exploration of this potential gene-environment interaction would benefit from the development of a suitable animal model. Utilizing a previously described mouse model that is genetically predisposed to prostate cancer through a prostate-specific heterozygous PTEN deletion, termed C57/Luc/Ptenp+/-, we used bioluminescence imaging and histopathological analyses to test whether chronic exposure to chlorpyrifos in a grain-based diet for 32 weeks was able to promote prostate cancer development. Chronic exposure to chlorpyrifos in the diet did not promote prostate cancer development in C57/Luc/Ptenp+/- mice despite achieving sufficient levels to inhibit acetylcholinesterase activity in plasma. We found no significant differences in numbers of murine prostatic intraepithelial neoplasia lesions or disease progression in chlorpyrifos versus control treated animals up to 32 weeks. The mechanistic basis of pesticide-induced prostate cancer may be complex and may involve other genetic variants, multiple genes, or nongenetic factors that might alter prostate cancer risk during pesticide exposure in agricultural workers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758150      PMCID: PMC3951157          DOI: 10.1615/jenvironpatholtoxicoloncol.2013006778

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  34 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Genetic variation in paraoxonase activity and sensitivity to diisopropylphosphofluoridate in inbred mice.

Authors:  J M Wehner; C Murphy-Erdosh; A Smolen; T N Smolen
Journal:  Pharmacol Biochem Behav       Date:  1987-10       Impact factor: 3.533

3.  Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.

Authors:  T M Trybus; A C Burgess; K J Wojno; T W Glover; J A Macoska
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

4.  Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.

Authors:  Robert U Svensson; Jessica M Haverkamp; Daniel R Thedens; Michael B Cohen; Timothy L Ratliff; Michael D Henry
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

5.  Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort.

Authors:  Michael C R Alavanja; Claudine Samanic; Mustafa Dosemeci; Jay Lubin; Robert Tarone; Charles F Lynch; Charles Knott; Kent Thomas; Jane A Hoppin; Joseph Barker; Joseph Coble; Dale P Sandler; Aaron Blair
Journal:  Am J Epidemiol       Date:  2003-05-01       Impact factor: 4.897

6.  Loss of the chromosomal region 10q23-25 in prostate cancer.

Authors:  I C Gray; S M Phillips; S J Lee; J P Neoptolemos; J Weissenbach; N K Spurr
Journal:  Cancer Res       Date:  1995-11-01       Impact factor: 12.701

Review 7.  Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

Authors:  Scott B Shappell; George V Thomas; Richard L Roberts; Ron Herbert; Michael M Ittmann; Mark A Rubin; Peter A Humphrey; John P Sundberg; Nora Rozengurt; Roberto Barrios; Jerrold M Ward; Robert D Cardiff
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

8.  Allelic loss on chromosome 10 in prostate adenocarcinoma.

Authors:  M Ittmann
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

9.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

10.  Myc-driven murine prostate cancer shares molecular features with human prostate tumors.

Authors:  Katharine Ellwood-Yen; Thomas G Graeber; John Wongvipat; M Luisa Iruela-Arispe; JianFeng Zhang; Robert Matusik; George V Thomas; Charles L Sawyers
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.